Search
for
Sort by
Research 301–330 of 1000+
- Ovarian Stromal Hyperthecosis and Hyperandrogenemia Refractory to Hormonal Suppression
- The Case of the Elusive Androgen
- Baricitinib in the Treatment of Frontal Fibrosing Alopecia: Mid Trial Update
- Frontal Fibrosing Alopecia – a review and a practical guide for clinicians
- SUN-005 Hirsutism Due to Bilateral Leydig Cell Tumors
- MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
- Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study
- Alopecia induced by dopamine agonists
- The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis
- Frontal fibrosing alopecia and lichen planus pigmentosus: diagnosis and therapeutic challenge
- Fibrothecoma of Ovary with Virilizing Features
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Testosterone Treatment in Women – An Overview
- Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes
- Increased blood level of urea and creatinine after chemotherapy in breast cancer patients
- Epidemiological landscape of androgenetic alopecia in the US: An All of Us cross-sectional study
- The Need and Management of hormone Imbalances in Women
- Rare steroid cell tumor found in region North Brazil: case report
- SUN-376 Isolated DHEA-S Production by an Adrenal Neoplasm: Clinical, Biochemical, and Pathologic Findings
- DEFINITION OF FRONTAL FIBROSING ALOPECIA IN THE GROUP OF SCARRING ALOPECIAS
- A review of the role of estrogen in dermal aging and facial attractiveness in women
- Frontal fibrosing alopecia: clinical presentations and prognosis
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- An 88-year-old woman with flushing, alopecia and hirsutism and a Sertoli-Leydig cell tumour
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Leydig cell ovarian tumour: a rare cause of hyperandrogenism
- SUN-115 Leydig Cell Tumor: A Rare Cause of Hyperandrogenism
- Hiperandrogenismo causado por tumor de células de Leydig de ovario